Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section
Recruiting
N/A
Interventional Study
Virtual Reality
Dexmedetomidine
Maternal Anxiety
Stress
Hemodynamics
Neonatal Outcomes
Cesarean Section
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 52 (estimated)
- Sponsor
- Benha University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age over 18 years old.
* American Society of Anesthesiologists (ASA) physical status II.
* Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
* Provide informed consent and agree to participate in the study.
Exclusion Criteria:
* Patient'…
Contacts